Latest filing published 15 Aug 2014 for ACHILLION PHARMACEUTICALS INC, €541k.
Insider track record
No signal scores available.
Michael D. Kishbauch: trading record in brief
Michael D. Kishbauch discloses dealings in 2 companies, chiefly Achillion Pharmaceuticals Inc and Ariad Pharmaceuticals Inc. We count 27 filings; the first trade dates from 17 January 2007 and the latest from 15 August 2014.
Every open-market trade on record is a sale: 12 sales worth €8.8M. The rest of the record consists of 15 option exercises. In 2014 alone, the filings show no purchases and 5 sales.
The latest filing, published on 15 August 2014, reports an option exercise of €541k in Achillion Pharmaceuticals Inc. Most trades are made public on the day they happen. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael D. Kishbauch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 150,000 shares@ US$4.82Common StockSEC:0001181431-14-029379:0
- 150,000 shares@ US$9.36Common StockSEC:0001181431-14-029379:1
- 158,000 shares@ US$1.05Common StockSEC:0001181431-14-029379:2
- 158,000 shares@ US$9.36Common StockSEC:0001181431-14-029379:3
- 133,125 shares@ US$3.28Common StockSEC:0001181431-14-029379:4
- 133,125 shares@ US$9.36Common StockSEC:0001181431-14-029379:5
- 54,687 shares@ US$7.59Common StockSEC:0001181431-14-029379:6
- 54,687 shares@ US$9.75Common StockSEC:0001181431-14-029379:7
- 371,937 shares@ US$3.10Common StockSEC:0001181431-14-023657:0
- 371,937 shares@ US$7.75Common StockSEC:0001181431-14-023657:1
- 81,309 shares@ US$1.60Common StockSEC:0001181431-12-002591:0
- 116,997 shares@ US$4.00Common StockSEC:0001181431-12-002591:1
- 198,306 shares@ US$12.63Common StockSEC:0001181431-12-002591:2
- 90,209 shares@ US$1.60Common StockSEC:0001181431-12-002267:0
- 90,209 shares@ US$10.01Common StockSEC:0001181431-12-002267:1
- 8,900 shares@ US$1.60Common StockSEC:0001181431-12-002267:2
- 8,900 shares@ US$12.50Common StockSEC:0001181431-12-002267:3
- 72,709 shares@ US$1.60Common StockSEC:0001181431-11-038923:0
- 72,709 shares@ US$7.58Common StockSEC:0001181431-11-038923:1
- 10,200 shares@ US$1.60Common StockSEC:0001181431-11-038153:0
- 10,200 shares@ US$7.51Common StockSEC:0001181431-11-038153:1
- 5,500 shares@ US$1.60Common StockSEC:0001181431-11-038153:2
- 5,500 shares@ US$7.51Common StockSEC:0001181431-11-038153:3
- 1,800 shares@ US$1.60Common StockSEC:0001181431-11-038153:4
- 1,800 shares@ US$7.50Common StockSEC:0001181431-11-038153:5
25 of 27 declarations
